IGM Biosciences, Inc.

Pharmaceutical Preparations·MOUNTAIN VIEW, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2025	6/30/25	7/31/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K/A	FY 2024	12/31/24	4/30/25	→
10-K	FY 2024	12/31/24	3/6/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

26 shown

Filed	Period
1/10/25	Q4 FY2025	→
11/8/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
5/8/24	Q2 FY2024	→
3/7/24	Q1 FY2024	→
1/8/24	Q4 FY2024	→
↓

News (8-K)

31 shown

Filed	Type	Description
8/14/25	Delisting	Completion of Acquisition or Disposition of Assets	→
7/1/25	Exec Change	Entry into a Material Definitive Agreement	→
6/11/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
5/29/25	Agreement	Entry into a Material Definitive Agreement	→
5/8/25	Reg FD	Termination of a Material Definitive Agreement	→
3/6/25	Other	Costs Associated with Exit or Disposal Activities	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
8/14/25	S-8 POS	S-8 POS	→
8/14/25	S-8 POS	S-8 POS	→
8/14/25	S-8 POS	S-8 POS	→
8/14/25	S-8 POS	S-8 POS	→
8/14/25	S-8 POS	S-8 POS	→
8/14/25	S-8 POS	S-8 POS	→
↓

Filing History(710 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Nov 13, 2025

0001076809-25-000132

—

8.7 KB

15-12G

Aug 25, 2025

0001140361-25-03244015-12G

—

12.9 KB

SCHEDULE 13D/A

Aug 18, 2025

0001104659-25-079905

—

15.3 KB

Aug 18, 2025

0000950170-25-1098544

Aug 14, 2025

27.1 KB

SCHEDULE 13D/A

Aug 18, 2025

0000950170-25-109761

—

228.1 KB

SCHEDULE 13D/A

Aug 15, 2025

0001104659-25-079312

—

15.4 KB

Aug 15, 2025

0001104659-25-079307OWNERSHIP DOCUMENT

Aug 14, 2025

14.4 KB

EFFECT

Aug 14, 2025

9999999995-25-002610

—

1.8 KB

EFFECT

Aug 14, 2025

9999999995-25-002609

—

1.8 KB

EFFECT

Aug 14, 2025

9999999995-25-002606

—

1.8 KB

EFFECT

Aug 14, 2025

9999999995-25-002605

—

1.8 KB

EFFECT

Aug 14, 2025

9999999995-25-002604

—

1.8 KB

Aug 14, 2025

0001415889-25-022042

Aug 14, 2025

5.5 KB

Aug 14, 2025

0001104659-25-078832OWNERSHIP DOCUMENT

Aug 14, 2025

7.0 KB

Aug 14, 2025

0001415889-25-021975

Aug 14, 2025

8.8 KB

Aug 14, 2025

0001415889-25-021970

Aug 14, 2025

10.0 KB

Aug 14, 2025

0001415889-25-021964

Aug 14, 2025

11.8 KB

Aug 14, 2025

0001415889-25-021961

Aug 14, 2025

5.5 KB

Aug 14, 2025

0001415889-25-021960

Aug 14, 2025

5.4 KB

Aug 14, 2025

0001415889-25-021959

Aug 14, 2025

5.6 KB

Aug 14, 2025

0001415889-25-021950

Aug 14, 2025

10.6 KB

S-8 POS

Aug 14, 2025

0001140361-25-031239S-8 POS

—

29.4 KB

S-8 POS

Aug 14, 2025

0001140361-25-031238S-8 POS

—

29.4 KB

S-8 POS

Aug 14, 2025

0001140361-25-031236S-8 POS

—

29.4 KB

S-8 POS

Aug 14, 2025

0001140361-25-031233S-8 POS

—

29.4 KB

25 filings shown

Filed	Form	Description
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/15/24	PRE 14A	PRE 14A	→
4/27/23	DEFA14A	DEFA14A	→
4/27/23	DEF 14A	DEF 14A	→
4/27/22	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
↓

IGM Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(710 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
8/18/25	4	4	→
8/15/25	4	OWNERSHIP DOCUMENT	→
8/14/25	4	4	→
8/14/25	4	OWNERSHIP DOCUMENT	→
8/14/25	4	4	→
8/14/25	4	4	→
↓

Filed	Form	Description
11/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/25/25	15-12G	15-12G	→
8/18/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/18/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/15/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/14/25	EFFECT	EFFECT	→
↓